May 16 |
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
|
Apr 30 |
Axonics GAAP EPS of -$0.38 misses by $0.28, revenue of $91.4M beats by $1.62M
|
Apr 30 |
Axonics Reports First Quarter 2024 Financial Results
|
Apr 24 |
Boston Scientific Announces Results for First Quarter 2024
|
Apr 4 |
Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info on $3.7B deal
|
Mar 29 |
All You Need to Know About Axonics (AXNX) Rating Upgrade to Buy
|
Mar 14 |
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
|
Mar 8 |
Boston Scientific pulls, refiles HSR notification for Axonics deal
|
Mar 6 |
Axonics ticks higher as Boston Scientific reiterates close in 1H24
|
Mar 1 |
Medtronic accuses Axonics of patent infringement, files ITC complaint
|